BioScrip Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
53,606.00
143,382.00
303,428.00
36,172.00
63,303.00
51,592
Depreciation, Depletion & Amortization
20,226.00
22,943.00
22,743.00
22,025.00
27,725.00
23,601
Other Funds
2,549.00
1,100.00
108.00
202.00
120.00
24,527
Funds from Operations
22,116.00
107,160.00
43,454.00
32,279.00
18,371.00
3,398
Changes in Working Capital
32,437.00
75,744.00
21,288.00
10,262.00
17,608.00
16,706
Net Operating Cash Flow
54,553.00
31,416.00
64,742.00
42,541.00
763.00
20,104
Capital Expenditures
25,626.00
13,829.00
11,544.00
9,870.00
8,680.00
Sale of Fixed Assets & Businesses
-
-
-
4,177.00
-
Purchase/Sale of Investments
6,254.00
852.00
-
-
-
Net Investing Cash Flow
302,370.00
44,257.00
13,021.00
73,209.00
8,680.00
Issuance/Reduction of Debt, Net
174,892.00
14,202.00
6,975.00
26,677.00
23,384.00
Net Financing Cash Flow
295,823.00
13,102.00
66,558.00
109,742.00
44,281.00
Net Change in Cash
61,100.00
261.00
14,837.00
6,008.00
34,838.00
Free Cash Flow
80,179.00
45,245.00
76,286.00
52,411.00
9,443.00
Deferred Taxes & Investment Tax Credit
4,816.00
12,318.00
20,089.00
2,045.00
3,379.00
66
Net Assets from Acquisitions
282,998.00
454.00
-
67,516.00
-
Other Sources
-
57,688.00
24,565.00
-
-
Change in Capital Stock
118,382.00
-
59,691.00
83,267.00
20,777.00

About BioScrip

View Profile
Address
1600 Broadway
Denver Colorado 80202
United States
Employees -
Website http://www.bioscrip.com
Updated 07/08/2019
BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The firm offers post-acute solutions, infusion services, and respiratory care services and home medical equipment.